Annual Revenue ($)

Immune Therapeutics revenue was $113.50 k in FY, 2018

Quarterly Revenue ($)

FY, 2015FY, 2016FY, 2018
Revenue$16.20 k$3.46 k$113.50 k
Growth(78.62%)
Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q3, 2017Q1, 2018Q2, 2018
Revenue$0$2.07 k$5.65 k$4.96 k$3.46 k$0$65.01 k$65.01 k